|
Apr 15
|
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)
|
|
Apr 15
|
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
|
|
Mar 26
|
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
|
|
Jan 3
|
Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats
|
|
Dec 7
|
Optimi Health and Sunshine Earth Labs Ltd. Forge Strategic Supply Agreement
|
|
Nov 28
|
Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing
|
|
Nov 10
|
Optimi Health Resolves Dispute
|
|
Nov 7
|
Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer
|
|
Aug 10
|
Optimi Health Announces CAD $3,000,000 Senior Debt Financing
|